Your browser is no longer supported. Please, upgrade your browser.
DGX Quest Diagnostics Incorporated monthly Stock Chart
DGX [NYSE]
Quest Diagnostics Incorporated
IndexS&P 500 P/E22.76 EPS (ttm)5.50 Insider Own0.50% Shs Outstand134.00M Perf Week-1.46%
Market Cap16.72B Forward P/E14.02 EPS next Y8.93 Insider Trans-34.02% Shs Float133.63M Perf Month8.08%
Income749.00M PEG2.21 EPS next Q3.39 Inst Own92.10% Short Float2.39% Perf Quarter11.58%
Sales7.53B P/S2.22 EPS this Y18.70% Inst Trans-1.13% Short Ratio2.21 Perf Half Y12.35%
Book/sh43.51 P/B2.88 EPS next Y4.97% ROA6.00% Target Price126.43 Perf Year23.69%
Cash/sh7.40 P/C16.92 EPS next 5Y10.30% ROE13.20% 52W Range73.02 - 131.81 Perf YTD17.25%
Dividend2.24 P/FCF31.73 EPS past 5Y10.20% ROI9.40% 52W High-5.01% Beta1.37
Dividend %1.79% Quick Ratio1.20 Sales past 5Y0.80% Gross Margin34.10% 52W Low71.47% ATR3.18
Employees47000 Current Ratio1.30 Sales Q/Q-6.50% Oper. Margin15.10% RSI (14)53.76 Volatility2.47% 2.56%
OptionableYes Debt/Eq0.78 EPS Q/Q-10.70% Profit Margin9.90% Rel Volume0.76 Prev Close124.51
ShortableYes LT Debt/Eq0.69 EarningsJul 23 BMO Payout38.30% Avg Volume1.44M Price125.21
Recom2.30 SMA20-0.02% SMA505.55% SMA20016.92% Volume1,102,033 Change0.56%
Jul-29-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $144
Jul-14-20Upgrade BofA Securities Neutral → Buy $142
Jun-09-20Upgrade Wells Fargo Underweight → Equal Weight $90 → $120
Jun-02-20Upgrade Deutsche Bank Hold → Buy $140
Apr-28-20Upgrade Morgan Stanley Equal-Weight → Overweight $139
Apr-27-20Upgrade Wolfe Research Underperform → Peer Perform
Apr-27-20Upgrade Citigroup Neutral → Buy $113 → $130
Mar-27-20Downgrade Morgan Stanley Overweight → Equal-Weight $95
Jan-08-20Initiated Wells Fargo Underweight $100
Jan-07-20Downgrade Barclays Overweight → Equal Weight $106
Dec-19-19Upgrade BofA/Merrill Underperform → Neutral $94 → $110
Jul-15-19Downgrade Goldman Neutral → Sell $90 → $85
Apr-02-19Upgrade Jefferies Hold → Buy $93 → $107
Mar-18-19Resumed Credit Suisse Neutral $101 → $91
Jan-31-19Downgrade Argus Buy → Hold
Jan-17-19Initiated UBS Neutral $90
Jan-03-19Downgrade BofA/Merrill Neutral → Underperform
Dec-03-18Downgrade BofA/Merrill Buy → Neutral
Nov-30-18Downgrade Goldman Buy → Neutral
Oct-19-18Resumed BofA/Merrill Buy
Aug-06-20 04:21PM  
Aug-04-20 06:00PM  
Aug-03-20 04:05PM  
08:30AM  
Jul-30-20 03:58AM  
Jul-29-20 10:07PM  
05:19PM  
04:10PM  
11:51AM  
09:38AM  
Jul-27-20 11:50AM  
08:57AM  
Jul-26-20 09:10AM  
Jul-24-20 02:06PM  
12:38AM  
Jul-23-20 07:01PM  
11:23AM  
10:14AM  
09:24AM  
08:05AM  
07:16AM  
06:57AM  
06:45AM  
Jul-22-20 11:30AM  
08:34AM  
05:30AM  
Jul-21-20 02:50PM  
09:04AM  
08:41AM  
07:47AM  
Jul-20-20 09:57AM  
09:31AM  
08:52AM  
06:24AM  
03:33AM  
Jul-19-20 11:23PM  
Jul-18-20 01:30PM  
Jul-17-20 12:56PM  
11:13AM  
09:15AM  
Jul-16-20 09:19PM  
12:31PM  
12:00PM  
12:00PM  
Jul-15-20 05:25PM  
08:01AM  
Jul-14-20 12:47PM  
11:40AM  
11:35AM  
10:26AM  
Jul-13-20 07:15AM  
07:02AM  
06:45AM  
Jul-08-20 08:48AM  
08:41AM  
08:39AM  
08:02AM  
07:03AM  
Jul-07-20 06:32PM  
10:24AM  
10:21AM  
Jul-06-20 09:30AM  
09:28AM  
Jul-03-20 12:10PM  
11:30AM  
09:39AM  
08:30AM  
Jul-02-20 10:04AM  
08:46AM  
06:56AM  
Jul-01-20 08:35AM  
Jun-30-20 10:40AM  
09:37AM  
09:37AM  
08:35AM  
Jun-29-20 11:27AM  
09:44AM  
07:19AM  
Jun-25-20 11:05AM  
09:02AM  
Jun-24-20 09:50AM  
09:25AM  
08:15AM  
08:00AM  
07:00AM  
Jun-23-20 05:32PM  
04:05PM  
11:37AM  
10:52AM  
10:03AM  
10:01AM  
09:24AM  
Jun-19-20 10:14AM  
09:13AM  
Jun-18-20 11:47AM  
11:40AM  
11:06AM  
09:39AM  
Jun-16-20 12:17PM  
09:46AM  
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated has a strategic collaboration with hc1; and strategic relationship with Clinical Genomics Pty Ltd. The company was founded in 1967 and is headquartered in Secaucus, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RING TIMOTHY MDirectorJun 08Option Exercise58.5011,730686,20932,235Jun 10 04:31 PM
GUINAN MARKExecutive Vice President & CFOJun 08Option Exercise71.1772,5965,166,657146,175Jun 10 04:33 PM
RING TIMOTHY MDirectorJun 08Sale116.6011,7301,367,71820,505Jun 10 04:31 PM
GUINAN MARKExecutive Vice President & CFOJun 08Sale117.2372,5968,510,58573,579Jun 10 04:33 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentApr 27Option Exercise71.1711,717833,899249,464Apr 28 04:45 PM
EGLINTON MANNER CARRIESVP, Advanced DiagnosticsApr 27Sale111.025,000555,07522,390Apr 28 04:37 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentApr 27Sale112.0111,7171,312,433237,747Apr 28 04:45 PM
Davis J. E.EVP, General DiagnosticsMar 16Sale87.753,513308,25138,086Mar 17 04:37 PM
PREVOZNIK MICHAEL ESVP & General CounselMar 11Sale104.252,175226,74440,087Mar 12 05:00 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Mar 11Sale104.252,501260,72968,411Mar 12 04:57 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMar 10Option Exercise71.171007,117237,847Mar 12 04:55 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMar 10Sale112.1910011,219237,747Mar 12 04:55 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMar 06Option Exercise71.17230,17816,381,768456,738Mar 10 04:38 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMar 06Sale112.67230,17825,934,978226,560Mar 10 04:38 PM
PREVOZNIK MICHAEL ESVP & General CounselFeb 27Sale109.0269075,22440,087Feb 28 05:53 PM
Davis J. E.EVP, General DiagnosticsFeb 27Sale109.021,100119,92238,105Feb 28 05:50 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Feb 27Sale109.0278986,01768,411Feb 28 05:51 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Feb 26Sale111.0936840,88169,977Feb 28 05:51 PM
Davis J. E.EVP, General DiagnosticsFeb 26Sale111.0951056,65640,392Feb 28 05:50 PM
PREVOZNIK MICHAEL ESVP & General CounselFeb 26Sale111.0932135,66041,445Feb 28 05:53 PM
Davis J. E.EVP, General DiagnosticsFeb 25Sale112.7359867,41341,454Feb 26 04:34 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Feb 25Sale112.7340545,65670,701Feb 26 04:31 PM
Davis J. E.EVP, General DiagnosticsJan 02Option Exercise68.64143,5469,853,318180,080Jan 03 04:39 PM
Davis J. E.EVP, General DiagnosticsJan 02Sale105.57143,53715,153,86436,543Jan 03 04:39 PM
PREVOZNIK MICHAEL ESVP & General CounselNov 27Option Exercise55.0744,5562,453,56584,014Dec 04 04:32 PM
PREVOZNIK MICHAEL ESVP & General CounselNov 27Sale107.4344,5564,786,56439,458Dec 04 04:32 PM
WILENSKY GAIL RDirectorNov 26Option Exercise55.768,000446,08022,951Nov 27 04:43 PM
WILENSKY GAIL RDirectorNov 26Sale107.178,000857,35214,951Nov 27 04:43 PM
DEPPE MICHAEL JVP, Corp. Controller & CAOSep 17Option Exercise55.655,000278,25028,671Sep 19 04:29 PM
DEPPE MICHAEL JVP, Corp. Controller & CAOSep 17Sale106.005,000530,00023,732Sep 19 04:29 PM